Our previous studies [3] have shown that the increased activity of intracellular survival signaling pathways—PI3K-Akt/PKB-mTOR and Ras-Raf-MEK-ERK—is responsible for the resistance of glioma cells to their elimination by apoptosis. The gene discussed is MAP2K7; the disease is central nervous system cancer.